The novel antibody therapies market for advanced stage drugs is anticipated to grow at a CAGR of 36%
Given
the potential of novel antibody therapies in the treatment of oncological
disorders, there is a growing interest in evaluating such therapy candidates
against other life-threatening disease indications as well
<... Continue